-
EP3203396
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3203396
| EP3203396 - SYSTEM AND METHOD FOR ANALYZING GLUCOSE MONITORING DATA INDICATIVE OF A GLUCOSE LEVEL, AND A COMPUTER PROGRAM PRODUCT [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 21.05.2019 Database last updated on 11.05.2024 | |
| Former | Request for examination was made Status updated on 16.02.2018 | ||
| Former | The application has been published Status updated on 07.07.2017 | Most recent event Tooltip | 05.03.2024 | Change: Date of oral proceedings | 05.03.2024 | Deletion: Despatch of minutes of oral proceedings | Applicant(s) | For:DE
Roche Diabetes Care GmbH Sandhofer Straße 116 68305 Mannheim / DE | For:AL
AT
BE
BG
CH
CY
CZ
DK
EE
ES
FI
FR
GB
GR
HR
HU
IE
IS
IT
LI
LT
LU
LV
MC
MK
MT
NL
NO
PL
PT
RO
RS
SE
SI
SK
SM
TR
F. Hoffmann-La Roche AG Grenzacherstrasse 124 4070 Basel / CH | [2017/32] | Inventor(s) | 01 /
Koehler, Matthias Hurststraße 4A 69514 Laudenbach / DE | 02 /
Wiedemann, Timm Wilhelm-Peters-Straße 150 68219 Mannheim / DE | [2017/32] | Representative(s) | Bittner, Thomas L. Boehmert & Boehmert Anwaltspartnerschaft mbB Pettenkoferstrasse 22 80336 München / DE | [2017/32] | Application number, filing date | 16153964.8 | 02.02.2016 | [2017/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3203396 | Date: | 09.08.2017 | Language: | EN | [2017/32] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 25.07.2016 | Classification | IPC: | G06F19/00 | [2017/32] | CPC: |
G16H40/63 (EP,US);
A61B5/14532 (US);
A61B5/7275 (US);
A61B5/742 (US);
G16H10/60 (EP,US)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/12] |
| Former [2017/32] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | SYSTEM UND VERFAHREN ZUR ANALYSE VON GLUCOSEÜBERWACHUNGSDATEN, DIE DEN BLUTZUCKERSPIELGEL ANGEBEN, UND COMPUTERPROGRAMMPRODUKT | [2017/32] | English: | SYSTEM AND METHOD FOR ANALYZING GLUCOSE MONITORING DATA INDICATIVE OF A GLUCOSE LEVEL, AND A COMPUTER PROGRAM PRODUCT | [2017/32] | French: | SYSTÈME ET PROCÉDÉ D'ANALYSE DE DONNÉES DE SURVEILLANCE DU GLUCOSE INDIQUANT UN NIVEAU DE GLUCOSE ET PRODUIT DE PROGRAMME INFORMATIQUE | [2017/32] | Examination procedure | 02.02.2016 | Date on which the examining division has become responsible | 09.02.2018 | Amendment by applicant (claims and/or description) | 09.02.2018 | Examination requested [2018/12] | 24.05.2019 | Despatch of a communication from the examining division (Time limit: M04) | 27.09.2019 | Reply to a communication from the examining division | 28.01.2022 | Date of oral proceedings | 08.02.2022 | Minutes of oral proceedings despatched | 16.02.2022 | Despatch of communication that the application is refused, reason: substantive examination {1} | Appeal following examination | 14.04.2022 | Appeal received No. T1741/22 | 14.04.2022 | Payment of appeal fee | 24.06.2022 | Statement of grounds filed | 26.07.2024 | Date of oral proceedings | Fees paid | Renewal fee | 07.02.2018 | Renewal fee patent year 03 | 08.02.2019 | Renewal fee patent year 04 | 10.02.2020 | Renewal fee patent year 05 | 09.02.2021 | Renewal fee patent year 06 | 09.02.2022 | Renewal fee patent year 07 | 09.02.2023 | Renewal fee patent year 08 | 20.02.2024 | Renewal fee patent year 09 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US2014188400 (DUNN TIMOTHY C [US], et al) [Y] 1-11 * paragraphs [0193] - [0194]; figures 20-22 *; | [Y] - DAVID RODBARD ET AL, "Interpretation of Continuous Glucose Monitoring Data: Glycemic Variability and Quality of Glycemic Control", DIABETIS TECHNOLOGY & THERAPEUTICS, MARY ANN LIEBERT, LARCHMONT, NY; US, (20090602), vol. 11, no. s1, doi:10.1089/dia.2008.0132, ISSN 1520-9156, pages S - 55, XP055288717 [Y] 1-11 * table 1 * DOI: http://dx.doi.org/10.1089/dia.2008.0132 | by applicant | - MATTHAEI, "Assessing the value of the Ambulatory Glucose Profile in clinical practice", THE BRITISH JOURNAL OF DIABETES AND VASCULAR DISEASE | - MAZZE ET AL., "Ambulatory Glucose Profile representation of verified self-monitored blood glucose data", DIABETES CARE, (1987), vol. 10, pages 111 - 117 | - BERGENSTAL ET AL., "Recommendation for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: The Ambulatory Glucose Profile (AGP", DIABETES TECHNOL THER, (2013), vol. 15, pages 198 - 211 |